Cat. No.: DMM-001246
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | These mice carry a spontaneous mutation at the Lepr locus on a C57BL/6J background and are characterized by compensatory hyperplasia of the islet B-cells and hyperinsulinemia. Wound healing is delayed, and metabolic efficiency is increased. The strain carries the misty mutation (Dock7m) to aid in early identification of homozygotes. |
| Strain Name | B6.Cg-Dock7m Leprdb/+ +/J |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | Lepr |
| Synonyms | OBR, CD295, HuB219, LEP-R |
| Gene ID | 3953 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.